Know the Latest About COVID-19 MAbs and Remdesivir

Questions are popping up about changes with COVID-19 monoclonal antibodies (MAbs) and remdesivir.

Treatment. If oral nirmatrelvir/ritonavir (Paxlovid) is not an option, use the IV MAb sotrovimab for mild to moderate COVID-19.

Consider it for OUTpatients positive for COVID-19 who are at high risk of severe illness (diabetes, etc)...regardless of vaccination status.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote